Eam Investors, LLC Mei Pharma, Inc. Transaction History

Eam Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$2.46 - $4.27 $1.09 Million - $1.9 Million	-444,826 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.45 - $4.3 $644,997 - $1.91 Million	444,826 New	444,826 $1.84 Million
Q4 2018 Feb 13, 2019	SELL	$1.92 - $4.1 $717,866 - $1.53 Million	-373,889 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$3.39 - $4.61 $1,817 - $2,470	536 Added 0.14%	373,889 $1.61 Million
Q2 2018 Aug 03, 2018	BUY	$1.89 - $4.95 $705,637 - $1.85 Million	373,353 New	373,353 $1.47 Million
Q4 2017 Feb 12, 2018	SELL	$1.91 - $2.83 $367,126 - $543,962	-192,213 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$2.44 - $2.91 $468,999 - $559,339	192,213	192,213 $515,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $333M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.